Tau filaments from multiple cases of sporadic and inherited Alzheimer’s disease adopt a common fold

Benjamin Falcon, Wenjuan Zhang, Manuel Schweighauser, Alexey G. Murzin, Rubén Vidal, Holly J. Garringer, Bernardino Ghetti, Sjors H. W. Scheres, Michel Goedert

TL;DR

This study reveals that tau filaments, the hallmark of Alzheimer's disease, share a remarkably consistent structural fold across multiple individuals with both sporadic and inherited forms of the disease. This finding is crucial for understanding how these toxic protein aggregates form and for developing targeted therapies.

What Problem Does This Paper Address?

Alzheimer's disease (AD) is characterized by the accumulation of abnormal protein aggregates in the brain. One key player is the tau protein, which forms filamentous structures called neurofibrillary tangles. While it's known that tau filaments exist in two main forms – paired helical filaments (PHFs) and straight filaments (SFs) – a critical unanswered question was whether the precise structure of these filaments varied between different individuals with AD, or even within different regions of the same brain. Such variations could imply different disease mechanisms or necessitate different therapeutic approaches for each individual. This paper aims to resolve this by determining the high-resolution structures of tau filaments from a diverse set of AD cases.

Methods

The researchers employed a powerful combination of techniques:

  • Electron Cryo-Microscopy (cryo-EM): This is the primary method for determining the high-resolution, three-dimensional structures of the tau filaments. They used advanced helical reconstruction techniques to build atomic models of the filaments.
  • Immuno-gold Negative-Stain Electron Microscopy (immuno-EM): This technique was used to map the composition of the tau filaments. Antibodies specific to different regions of the tau protein were used to "tag" the filaments, and their binding patterns revealed which parts of tau were exposed or buried within the filament core. Pronase treatment was used to remove the outer "fuzzy coat" of the filaments, allowing researchers to pinpoint the core components.

Datasets

The study analyzed tau filaments extracted from the frontal cortex of 17 individuals with typical AD (15 sporadic, 2 inherited) and 2 individuals with atypical AD (posterior cortical atrophy). For detailed structural analysis using cryo-EM, three cases of typical AD (two sporadic, one inherited) were used. Immuno-EM was applied to a broader range of samples, including the frontal cortex from 15 sporadic AD cases, 2 atypical AD cases, and 1 inherited AD case, as well as tau filaments from various brain regions (temporal, occipital, parietal, and cingulate cortices, thalamus, substantia innominata, and putamen) of one AD case.

Key Insights and Ideas

  • A Universal Tau Fold in AD: The most striking finding is that tau filaments, regardless of whether the AD is sporadic or inherited, and across different brain regions, adopt a highly conserved structural fold. This suggests a common underlying mechanism for filament formation in AD.
  • Protofilament Architecture: Both PHFs and SFs are built from two identical C-shaped protofilaments. These protofilaments themselves have a complex cross-β/β-helix structure.
  • Core Composition is Conserved: Immuno-EM revealed that the core of tau filaments in all analyzed AD cases and brain regions consistently contains repeats 3 and 4 of the tau protein, while repeats 1 and 2 are not part of the core. This is a significant insight into the molecular basis of filament formation.
  • Fine Details of the Fold: Higher resolution cryo-EM structures revealed additional amino acids at the ends of the protofilament structure, providing a more complete picture of the ordered core.
  • Implications for Therapeutics: Knowing that the structure is conserved simplifies the challenge of developing targeted therapies. Instead of needing to design drugs for multiple filament variants, researchers can focus on a single, common structure.

Key Results

  • High-resolution cryo-EM structures of PHFs and SFs were determined for multiple AD cases, revealing a consistent C-shaped protofilament fold.
  • Immuno-EM confirmed that repeats 3 and 4 of tau form the core of filaments in all analyzed AD cases and brain regions, while repeats 1 and 2 are excluded.
  • The study demonstrated that PHFs are the predominant form of tau filaments in all cases examined.
  • The structural findings were consistent across sporadic and inherited forms of AD, as well as atypical AD presentations.

Limitations and Future Work

  • Low-Throughput of Cryo-EM: The authors acknowledge that cryo-EM is a low-throughput technique, which is why immuno-EM was crucial for analyzing a larger number of cases and brain regions.
  • Early Stages of Assembly: The current study focuses on the final assembled filaments. The mechanisms by which tau assembly begins and how initial seeds form remain an area for future investigation. The authors suggest that cofactors like heparin or chemical modifications might be involved.
  • Extending to Other Tauopathies: While this study focuses on AD, it raises the question of whether other tauopathies (diseases characterized by tau pathology) also exhibit conserved filament structures. The authors note that Pick's disease, for example, has a distinct tau filament fold. Future work could explore the structural diversity of tau filaments across the spectrum of human tauopathies.
  • Therapeutic Development: The knowledge gained about the conserved structure is a critical step towards developing highly specific diagnostic ligands and targeted therapies aimed at disrupting tau filament formation or propagation.

Summary updated

Abstract

Abstract The ordered assembly of tau protein into abnormal filaments is a defining characteristic of Alzheimer’s disease (AD) and other neurodegenerative disorders. It is not known if the structures of tau filaments vary within, or between, the brains of individuals with AD. We used a combination of electron cryo-microscopy (cryo-EM) and immuno-gold negative-stain electron microscopy (immuno-EM) to determine the structures of paired helical filaments (PHFs) and straight filaments (SFs) from the frontal cortex of 17 cases of typical AD (15 sporadic and 2 inherited) and 2 cases of atypical AD (posterior cortical atrophy). The high-resolution structures of PHFs and SFs from the frontal cortex of 3 cases of typical AD, 2 sporadic and 1 inherited, were determined by cryo-EM. We also used immuno-EM to study the PHFs and SFs from a number of cortical and subcortical brain regions. PHFs outnumbered SFs in all AD cases. By cryo-EM, PHFs and SFs were made of two C-shaped protofilaments with a combined cross-β/β-helix structure, as described previously for a case of AD. The higher resolution structures obtained here showed two additional amino acids at each end of the protofilament structure. The immuno-EM findings, which established the presence of repeats 3 and 4, but not repeats 1 and 2, of tau in the filament cores of all AD cases and brain regions thereof, were consistent with the cryo-EM results. These findings show that there is no significant variation in tau filament structures between individuals with AD. This knowledge will be crucial for understanding the mechanisms that underlie tau filament formation and for developing novel diagnostics and therapies.
BibTeX
@inproceedings{falcon2018tau,
  author = {Benjamin Falcon and Wenjuan Zhang and Manuel Schweighauser and Alexey G. Murzin and Rubén Vidal and Holly J. Garringer and Bernardino Ghetti and Sjors H. W. Scheres and Michel Goedert},
  title = {{Tau filaments from multiple cases of sporadic and inherited Alzheimer’s disease adopt a common fold}},
  booktitle = {Apollo},
  year = {2018},
  doi = {10.17863/cam.33326},
}
Figure